Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene

Neurology

Volumn 54, Issue 8, 2000, Pages 1641-1646

  Hauw, J J ^a   Sazdovitch, V ^a   Laplanche, J L ^b   Peoc'h, K ^b   Kopp, N ^c   Kemeny, J ^d   Privat, N ^a   Delasnerie Laupretre N ^a   Brandel, J P ^a   Deslys, J P ^e   Dormont, D ^e   Alperovitch A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ LUMIÈRE LYON 2   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Creutzfeldt; Jakob disease; Neuropathology; Prion protein genotype

Indexed keywords

METHIONINE; VALINE;

ADULT; AGED; ARTICLE; CONFORMATIONAL TRANSITION; CREUTZFELDT JAKOB DISEASE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034008749     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.8.1641     Document Type: Article

References (38)

1. Brown P. Transmissible human spongiform encephalopathy (infectious cerebral amyloidosis): Creutzfeldt-Jakob disease, Gerstmann-Straüssler-Scheinker syndrome, and kuru, in Neurodegenerative diseases. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994:839-877.
2. Ironside J, Bell J. Pathology of prion diseases. In: Collinge J, Palmer M, eds. Prion diseases. Oxford: Oxford University Press, 1997:57-88.
3. McLean C, Ironside J, Alpers M, et al. Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 1998;8:429-437.
4. Hauw J-J, Sazdovitch V, Seilhean D, et al. The nosology and neuropathology of human conditions related to unconventional agents or Prions Eur J Neurol 1996;3:487-499.
5. Kitamono T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol 1992;141:271-277.
6. MacDonald S, Sutherland K, Ironside J. Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1996;22:285-292.
7. Parchi AU, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
8. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.
9. Collinge J, Hill AF, Side KCL. Typing prion isoforms (reply to Parchi et al., 1997). Nature 1997;386:233-234.
10. Parchi P, Capellari S, Chen SG, et al. Typing prion isoforms. Nature 1997;386:232-233.
11. Cardone F, Liu OG, Petraroli R, et al. Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients. Brain Res Bull 1999;49:429-433.
12. Alpérovitch A, Brandel JP, Chatelain J, et al. Incidence de la maladie de Creutzfeldt-Jakob en France. Le point au 30 Avril 1997. Bull Epid Hebd 1997;28:129-132.
13. van Duijn C, Delasnerie-Lauprêtre N, Masullo C, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1998;351:1081-1085.
14. Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459-466.
15. Kretzschmar H, Ironside J, DeArmond SJT. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53:913-920.
16. Brown P. A simple and effective method for inactivating virus infectivity in formalin-fixed tissues samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-890.
17. Perry R. A guide to the cortical regions. In: Roberts G, Leigh P, Weinberger D, eds. Neuropsychiatric disorders. London: Wolfe, 1993:1-10.
18. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril protein. J Virol 1987;61:3688-3693.
19. Hayward PAR, Bell JE, Ironside JW. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1994; 20:375-383.
20. Bell J, Gentleman S, Ironside J, et al. Prion protein immunocytochemistry - UK. Five centre consensus report. Neuropathol Appl Neurobiol 1997;23:26-35.
21. Privat N, Sazdovitch V, Seilhean D, Laplanche J, Hauw JJ. PrP immunohistochemistry: a new protocol and a proposed schematic classification for deposits. Microsc Res Tech 2000 (in press).
22. Kretzschmar HA, Kitamoto T, Doerr-Schott J, Mehraein P, Tateishi J. Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 1991;82:536-540.
23. Schulz-Schaeffer W, Giese A, Windl O, Kretzschmar H. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol 1996;15:353-357.
24. Antoine JC, Michel D, Bertholon P, Mosnier JF, Laplanche JL, Hauw J-J. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 1997;48:1451-1453.
25. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996;383:685-690.
26. Deslys JP, Lasmézas C, Streichenberger N, et al. New variant Creutzfeldt-Jakob disease in France. Lancet 1997;349:30-31.
27. Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, et al. Molecular genetics of prion diseases in France. Neurology 1994; 44:2347-2351.
28. De Silva R, Ironside JW, McCardle L, et al. Neuropathological phenotype and 'prion protein' genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1994;179:50-52.
29. Windl O, Dempster M, Estibeiro J, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996;98:259-264.
30. Brown P, Gibbs CJJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
31. Huillard d'Aignaux J, Laplanche J, Delasnerie-Lauprêtre N, et al. Trends in mortality from Creutzfeldt-Jakob disease in France between 1992 and 1997. J Neurol Neurosurg Psychiatry 2000 (in press).
32. Dlouhy S, Hsiao K, Farlow M, et al. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion-protein gene. Nat Genet 1992;1:64-67.
33. Poulter M, Baker HF, Frith C, et al. Inherited prion disease with 144 base pair insertion: I: Genealogical and molecular studies. Brain 1992;115:675-685.
34. Alpérovitch A, Zerr I, Pocchiari M, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999;353:1673-1674.
35. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK Lancet 1996;347:921-925.
36. Chazot G, Broussolle E, Lapras Cl, Blätter T, Aguzzi A, Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996;347:1181.
37. Birchard K. Variant Creutzfeldt-Jakob disease found in Ireland. Lancet 1999;353:2221.
38. Ironside J. Prion diseases in man. J Pathol 1998;186:227-234.